ELITE PHARMACEUTICALS INC /NV/·4

Feb 27, 4:59 PM ET

Ward Carter Julian 4

4 · ELITE PHARMACEUTICALS INC /NV/ · Filed Feb 27, 2018

Insider Transaction Report

Form 4
Period: 2018-02-26
Ward Carter Julian
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2018-02-26$0.12/sh+242,060$29,9912,127,364 total
Holdings
  • Common Stock

    (indirect: By IRA)
    1,355,014

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT